OUR PIPELINE

OUR PIPELINE

Our compounds in development target various stages of the HIV lifecycle.

View the ViiV Pipeline Bibliography

ViiV Healthcare Medical Pipeline
1

Binding and Fusion1

VH3810109 (N6LS)
Class: bNAb
Phase: IIb

VH4527079 (bi-specific)2
Class: bNAb
Phase: I

2

Nuclear Entry & Uncoating1

VH4011499
Class: Capsid Inhibitor
Phase: II

3

Integration1

Cabotegravir – ULA (Tx/PrEP)
Class: INSTI
Phase: Ia/IIb

VH45241843
Class: INSTI
Phase: IIa

VH4367310
Class: INSTI
Phase: Ia4

4

Assembly and Budding1

VH4011499
Class: Capsid Inhibitor
Phase: II

  1. GSK. ViiV Healthcare meet the management: Getting ahead of HIV together – 2023. Available at: https://www.gsk.com. Accessed April 2025
  2. NCT06652958. Available at: https://clinicaltrials.gov. Accessed April 2025.
  3. NCT06214052. Available at: https://clinicaltrials.gov. Accessed April 2025
  4. Baker M, et al.